{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:30:14Z","timestamp":1791819014713,"version":"4.3.4"},"reference-count":86,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:00Z","timestamp":1740355200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Rheumatoid arthritis (RA) is a systemic autoimmune disease that affects millions of people worldwide and is characterized by persistent inflammation, pain, and joint destruction. In RA, the dysregulation of the immune system is well documented. However, the genetic basis of the disease is not fully understood, especially when extra-articular organs are involved. Interstitial lung disease (ILD) is a major cause of morbidity and mortality in patients with RA. Notably, RA-ILD shares several risk factors with idiopathic pulmonary fibrosis (IPF), namely male gender, smoking history, usual interstitial pneumonia (UIP) pattern of fibrosis, and association with the <jats:italic>MUC5B<\/jats:italic> rs35705950 polymorphism. In addition, other genetic susceptibilities are reported in RA-ILD for some HLA alleles and other less studied polymorphisms. However, the pathobiology of RA-ILD, particularly whether and to what extent genetic and environmental factors interact to determine the disease, remains elusive. In this review, we summarize and critically discuss the most recent literature on the genetics and pathogenesis of RA-ILD. The main clinical aspects of RA-ILD are also discussed.<\/jats:p>","DOI":"10.3389\/fmed.2025.1542400","type":"journal-article","created":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T05:11:25Z","timestamp":1740373885000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Navigating interstitial lung disease associated with rheumatoid arthritis (RA-ILD): from genetics to clinical landscape"],"prefix":"10.3389","volume":"12","author":[{"given":"Nicol","family":"Bernardinello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Zen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gioele","family":"Castelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Cocconcelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Balestro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rapha\u00ebl","family":"Borie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Spagnolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,24]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis","volume":"388","author":"Smolen","year":"2016","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"123075","DOI":"10.1016\/j.lfs.2024.123075","article-title":"Genetics, epigenetics, and autoimmunity constitute a Bermuda triangle for the pathogenesis of rheumatoid arthritis","volume":"357","author":"Srivastava","year":"2024","journal-title":"Life Sci"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.3390\/cells10112857","article-title":"Management of rheumatoid arthritis: an overview","volume":"10","author":"Radu","year":"2021","journal-title":"Cells"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.berh.2017.08.003","article-title":"Genetic and environmental risk factors for rheumatoid arthritis","volume":"31","author":"Deane","year":"2017","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"e594","DOI":"10.1016\/S2665-9913(23)00211-4","article-title":"Global, regional, and national burden of rheumatoid arthritis, 1990-2020, and projections to 2050: a systematic analysis of the global burden of disease study 2021","volume":"5","year":"2023","journal-title":"Lancet Rheumatol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/s0889-857x(05)70201-5","article-title":"The epidemiology of rheumatoid arthritis","volume":"27","author":"Gabriel","year":"2001","journal-title":"Rheum Dis Clin N Am"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"S265","DOI":"10.1186\/ar578","article-title":"Epidemiology and genetics of rheumatoid arthritis","volume":"4","author":"Silman","year":"2002","journal-title":"Arthritis Res"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41413-018-0016-9","article-title":"Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies","volume":"6","author":"Guo","year":"2018","journal-title":"Bone Res"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1080\/14397595.2016.1265907","article-title":"Autoimmunity as a trigger for structural bone damage in rheumatoid arthritis","volume":"27","author":"Schett","year":"2017","journal-title":"Mod Rheumatol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41584-022-00793-5","article-title":"Mechanisms of joint destruction in rheumatoid arthritis - immune cell-fibroblast-bone interactions","volume":"18","author":"Komatsu","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/BOR.0000000000001006","article-title":"Autoantibodies in rheumatoid arthritis - rheumatoid factor, anticitrullinated protein antibodies and beyond","volume":"36","author":"Steiner","year":"2024","journal-title":"Curr Opin Rheumatol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"685312","DOI":"10.3389\/fimmu.2021.685312","article-title":"Autoantibodies in rheumatoid arthritis - laboratory and clinical perspectives","volume":"12","author":"R\u00f6nnelid","year":"2021","journal-title":"Front Immunol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"102776","DOI":"10.1016\/j.autrev.2021.102776","article-title":"Rheumatoid arthritis: extra-articular manifestations and comorbidities","volume":"20","author":"Figus","year":"2021","journal-title":"Autoimmun Rev"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"e22367","DOI":"10.7759\/cureus.22367","article-title":"Rheumatoid arthritis and associated lung diseases: a comprehensive review","volume":"14","author":"Azam","year":"2022","journal-title":"Cureus"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"210011","DOI":"10.1183\/16000617.0011-2021","article-title":"Rheumatoid arthritis-interstitial lung disease: manifestations and current concepts in pathogenesis and management","volume":"30","author":"Kadura","year":"2021","journal-title":"Eur Respir Rev"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"837133","DOI":"10.3389\/fmed.2022.837133","article-title":"Interstitial lung disease in rheumatoid arthritis: a practical review","volume":"9","author":"Laria","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1002\/art.40574","article-title":"The lung in rheumatoid arthritis: focus on interstitial lung disease","volume":"70","author":"Spagnolo","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.55563\/clinexprheumatol\/h9tc57","article-title":"Rheumatoid arthritis-associated interstitial lung disease: epidemiology, risk\/prognostic factors, and treatment landscape","volume":"39","author":"Fazeli","year":"2021","journal-title":"Clin Exp Rheumatol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"2332406","DOI":"10.1080\/07853890.2024.2332406","article-title":"The prevalence and risk factors of rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis","volume":"56","author":"Wang","year":"2024","journal-title":"Ann Med"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"220210","DOI":"10.1183\/16000617.0210-2022","article-title":"Prevalence, imaging patterns and risk factors of interstitial lung disease in connective tissue disease: a systematic review and meta-analysis","volume":"32","author":"Joy","year":"2023","journal-title":"Eur Respir Rev"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/BOR.0000000000000703","article-title":"Management issues in rheumatoid arthritis-associated interstitial lung disease","volume":"32","author":"England","year":"2020","journal-title":"Curr Opin Rheumatol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1136\/annrheumdis-2017-211138","article-title":"A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortality","volume":"76","author":"Hyldgaard","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1002\/art.42640","article-title":"Identification, monitoring, and Management of Rheumatoid Arthritis-Associated Interstitial Lung Disease","volume":"75","author":"Koduri","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1007\/s10067-020-04977-w","article-title":"Differentially expressed lncRNAs in peripheral blood mononuclear cells from middle-aged female patients with rheumatoid arthritis-associated interstitial lung disease","volume":"39","author":"Zhou","year":"2020","journal-title":"Clin Rheumatol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13244-022-01243-2","article-title":"Clinical and radiological features of lung disorders related to connective-tissue diseases: a pictorial essay","volume":"13","author":"Palmucci","year":"2022","journal-title":"Insights Imaging"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s11926-015-0546-8","article-title":"State-of-the-art imaging of the lung for connective tissue disease (CTD)","volume":"17","author":"Ohno","year":"2015","journal-title":"Curr Rheumatol Rep"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"100419","DOI":"10.1016\/j.ejro.2022.100419","article-title":"Connective tissue disease-related interstitial lung disease (CTD-ILD) and interstitial lung abnormality (ILA): evolving concept of CT findings, pathology and management","volume":"9","author":"Yoo","year":"2022","journal-title":"Eur J Radiol Open"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"103056","DOI":"10.1016\/j.autrev.2022.103056","article-title":"Pathogenesis, clinical features, and treatment strategy for rheumatoid arthritis-associated interstitial lung disease","volume":"21","author":"Akiyama","year":"2022","journal-title":"Autoimmun Rev"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1136\/thoraxjnl-2021-218577","article-title":"Genome-wide association study across five cohorts identifies five novel loci associated with idiopathic pulmonary fibrosis","volume":"77","author":"Allen","year":"2022","journal-title":"Thorax"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.job.2022.09.005","article-title":"A review on the role of salivary MUC5B in oral health","volume":"64","author":"Faruque","year":"2022","journal-title":"J Oral Biosci"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1056\/NEJMoa1013660","article-title":"A common MUC5B promoter polymorphism and pulmonary fibrosis","volume":"364","author":"Seibold","year":"2011","journal-title":"N Engl J Med"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/9712464","article-title":"The possible pathogenesis of idiopathic pulmonary fibrosis considering MUC5B","volume":"2019","author":"Zhang","year":"2019","journal-title":"Biomed Res Int"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12931-021-01694-z","article-title":"Prognostic role of MUC5B rs35705950 genotype in patients with idiopathic pulmonary fibrosis (IPF) on antifibrotic treatment","volume":"22","author":"Biondini","year":"2021","journal-title":"Respir Res"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/resp.14440","article-title":"MUC5B rs35705950 minor allele associates with older age and better survival in idiopathic pulmonary fibrosis","volume":"28","author":"van der Vis","year":"2023","journal-title":"Respirology"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa1801562","article-title":"MUC5B promoter variant and rheumatoid arthritis with interstitial lung disease","volume":"379","author":"Juge","year":"2018","journal-title":"N Engl J Med"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1002\/art.42162","article-title":"A risk score to detect subclinical rheumatoid arthritis-associated interstitial lung disease","volume":"74","author":"Juge","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"e002790","DOI":"10.1136\/rmdopen-2022-002790","article-title":"MUC5B promoter variant rs35705950, rare but significant susceptibility locus in rheumatoid arthritis-interstitial lung disease with usual interstitial pneumonia in Asian populations","volume":"8","author":"Joo","year":"2022","journal-title":"RMD Open"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1136\/thorax-2023-220856","article-title":"Rheumatoid arthritis and idiopathic pulmonary fibrosis: a bidirectional Mendelian randomisation study","volume":"79","author":"Leavy","year":"2024","journal-title":"Thorax"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1378\/chest.09-0444","article-title":"Rheumatoid arthritis-associated interstitial lung disease: the relevance of histopathologic and radiographic pattern","volume":"136","author":"Kim","year":"2009","journal-title":"Chest"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"2002533","DOI":"10.1183\/13993003.02533-2020","article-title":"Two sides of the same coin? A review of the similarities and differences between idiopathic pulmonary fibrosis and rheumatoid arthritis-associated interstitial lung disease","volume":"57","author":"Matson","year":"2021","journal-title":"Eur Respir J"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41556-022-00842-x","article-title":"Telomere dysfunction in ageing and age-related diseases","volume":"24","author":"Rossiello","year":"2022","journal-title":"Nat Cell Biol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41576-022-00527-z","article-title":"Genetics of human telomere biology disorders","volume":"24","author":"Revy","year":"2023","journal-title":"Nat Rev Genet"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1182\/hematology.2023000490","article-title":"Clinical manifestations of telomere biology disorders in adults","volume":"2023","author":"Niewisch","year":"2023","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1097\/MCP.0000000000000506","article-title":"Clinical implications of telomere dysfunction in lung fibrosis","volume":"24","author":"Molina-Molina","year":"2018","journal-title":"Curr Opin Pulm Med"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"2201383","DOI":"10.1183\/13993003.01383-2022","article-title":"European Respiratory Society statement on familial pulmonary fibrosis","volume":"61","author":"Borie","year":"2023","journal-title":"Eur Respir J"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1111\/resp.14168","article-title":"Pulmonary fibrosis associated with telomere-related gene mutations: a complex inheritance","volume":"26","author":"Borie","year":"2021","journal-title":"Respirology"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"5345","DOI":"10.1002\/jmv.28008","article-title":"Association between COVID-19 and telomere length: a bidirectional Mendelian randomization study","volume":"94","author":"Huang","year":"2022","journal-title":"J Med Virol"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"101048","DOI":"10.1016\/j.resmer.2023.101048","article-title":"Is telomere length a predictor of long-term survival in patients with COVID-19 pneumonia?","volume":"84","author":"Bernardinello","year":"2023","journal-title":"Respir Med Res"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"1023991","DOI":"10.3389\/fimmu.2023.1023991","article-title":"Assessing the association of leukocyte telomere length with ankylosing spondylitis and rheumatoid arthritis: a bidirectional Mendelian randomization study","volume":"14","author":"Wei","year":"2023","journal-title":"Front Immunol"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"1602314","DOI":"10.1183\/13993003.02314-2016","article-title":"Shared genetic predisposition in rheumatoid arthritis-interstitial lung disease and familial pulmonary fibrosis","volume":"49","author":"Juge","year":"2017","journal-title":"Eur Respir J"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"106943","DOI":"10.1016\/j.rmed.2022.106943","article-title":"Associations between shortened telomeres and rheumatoid arthritis-associated interstitial lung disease among U.S","volume":"201","author":"Natalini","year":"2022","journal-title":"Veterans Respir Med"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1136\/thorax-2023-220022","article-title":"Short peripheral blood leukocyte telomere length in rheumatoid arthritis-interstitial lung disease","volume":"79","author":"Doyle","year":"2024","journal-title":"Thorax"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.pulmoe.2020.11.005","article-title":"Telomere length across different UIP fibrotic-interstitial lung diseases: a prospective Greek case-control study","volume":"28","author":"Tomos","year":"2022","journal-title":"Pulmonology"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s00393-016-0209-9","article-title":"Association between shortened telomere length and rheumatoid arthritis: a meta-analysis","volume":"77","author":"Lee","year":"2018","journal-title":"Z Rheumatol"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1136\/ard.2006.059188","article-title":"Reduced telomere length in rheumatoid arthritis is independent of disease activity and duration","volume":"66","author":"Steer","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/resp.13977","article-title":"Diagnosis and management of connective tissue disease-associated interstitial lung disease in Australia and New Zealand: a position statement from the Thoracic Society of Australia and new Zealand","volume":"26","author":"Jee","year":"2021","journal-title":"Respirology"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/9710376","article-title":"Human leukocyte antigen (HLA) system: genetics and association with bacterial and viral infections","volume":"2022","author":"Medhasi","year":"2022","journal-title":"J Immunol Res"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1093\/rheumatology\/keaa232","article-title":"The genetics of rheumatoid arthritis","volume":"59","author":"Dedmon","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"101968","DOI":"10.1016\/j.berh.2024.101968","article-title":"Genetics of rheumatoid arthritis","volume":"38","author":"Sharma","year":"2024","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N Engl J Med"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B","article-title":"Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins","volume":"43","author":"MacGregor","year":"2000","journal-title":"Arthritis Rheum"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.3390\/biomedicines10061367","article-title":"Novel biomarkers, diagnostic and therapeutic approach in rheumatoid arthritis interstitial lung disease-a narrative review","volume":"10","author":"Florescu","year":"2022","journal-title":"Biomedicines"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"e33133","DOI":"10.1371\/journal.pone.0033133","article-title":"Association of human leukocyte antigen with interstitial lung disease in rheumatoid arthritis: a protective role for shared epitope","volume":"7","author":"Furukawa","year":"2012","journal-title":"PLoS One"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1093\/rheumatology\/keab441","article-title":"Pulmonary fibrosis in relation to genetic loci in an inception cohort of patients with early rheumatoid arthritis from northern Sweden","volume":"61","author":"J\u00f6nsson","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1164\/rccm.201505-1010OC","article-title":"MUC5B, and the response to N-acetylcysteine among individuals with idiopathic pulmonary fibrosis","volume":"192","author":"Oldham","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13023-021-01750-3","article-title":"Potential clinical utility of MUC5B und TOLLIP single nucleotide polymorphisms (SNPs) in the management of patients with IPF","volume":"16","author":"Bonella","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1164\/rccm.202312-2224LE","article-title":"TOLLIP SNP and antimicrobial treatment effect in idiopathic pulmonary fibrosis","volume":"210","author":"Whalen","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"16250","DOI":"10.1038\/s41598-021-95869-9","article-title":"Association of rs3750920 polymorphism in TOLLIP with clinical characteristics of fibrosing interstitial lung diseases in Japanese","volume":"11","author":"Isshiki","year":"2021","journal-title":"Sci Rep"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.rmed.2016.12.007","article-title":"FAM13A polymorphism as a prognostic factor in patients with idiopathic pulmonary fibrosis","volume":"123","author":"Hirano","year":"2017","journal-title":"Respir Med"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1136\/annrheumdis-2020-217256","article-title":"Association of the RPA3-UMAD1 locus with interstitial lung diseases complicated with rheumatoid arthritis in Japanese","volume":"79","author":"Shirai","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"rkae059","DOI":"10.1093\/rap\/rkae059","article-title":"RPA3-UMAD1 rs12702634 and rheumatoid arthritis-associated interstitial lung disease in European ancestry","volume":"8","author":"Juge","year":"2024","journal-title":"Rheumatol Adv Pract"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1177\/11772719221091758","article-title":"Lack of association of rs12702634 in RPA3-UMAD1 with interstitial lung diseases in Japanese rheumatoid arthritis patients","volume":"17","author":"Higuchi","year":"2022","journal-title":"Biomark Insights"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"rkac088","DOI":"10.1093\/rap\/rkac088","article-title":"A genome-wide association study identifying single nucleotide polymorphisms in the PPFIBP2 gene was predictive for interstitial lung disease in rheumatoid arthritis patients","volume":"6","author":"Hayashi","year":"2022","journal-title":"Rheumatol Adv Pract"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"rkad023","DOI":"10.1093\/rap\/rkad023","article-title":"Are genes the missing link to detect and prognosticate RA-ILD?","volume":"7","author":"Vermant","year":"2023","journal-title":"Rheumatol Adv Pract"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3899\/jrheum.2023-0588","article-title":"A call for gene expression analysis in whole blood of patients with rheumatoid arthritis (RA) as a biomarker for RA-associated interstitial lung disease","volume":"51","author":"Wierczeiko","year":"2024","journal-title":"J Rheumatol"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.3390\/cells12182235","article-title":"Molecular factors in PAD2 (PADI2) and PAD4 (PADI4) are associated with interstitial lung disease susceptibility in rheumatoid arthritis patients","volume":"12","author":"Nava-Quiroz","year":"2023","journal-title":"Cells"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/data9010005","article-title":"Single-nucleotide variants in PADI2 and PADI4 and ancestry informative markers in interstitial lung disease and rheumatoid arthritis among a Mexican mestizo population","volume":"9","author":"Nava-Quiroz","year":"2024","journal-title":"Data"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1164\/rccm.201004-0622OC","article-title":"Rheumatoid arthritis-interstitial lung disease-associated mortality","volume":"183","author":"Olson","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"152187","DOI":"10.1016\/j.semarthrit.2023.152187","article-title":"Survival of adults with rheumatoid arthritis associated interstitial lung disease - a systematic review and meta-analysis","volume":"60","author":"Farquhar","year":"2023","journal-title":"Semin Arthritis Rheum"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"e003491","DOI":"10.1136\/rmdopen-2023-003491","article-title":"Increased mortality in patients with RA-associated interstitial lung disease: data from a French administrative healthcare database","volume":"9","author":"Juge","year":"2023","journal-title":"RMD Open"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s12890-021-01569-5","article-title":"Mortality rate in rheumatoid arthritis-related interstitial lung disease: the role of radiographic patterns","volume":"21","author":"Nieto","year":"2021","journal-title":"BMC Pulm Med"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1183\/13993003.00357-2015","article-title":"Predictors of mortality in rheumatoid arthritis-associated interstitial lung disease","volume":"47","author":"Solomon","year":"2016","journal-title":"Eur Respir J"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s11926-024-01155-8","article-title":"Rheumatoid arthritis-associated interstitial lung disease (RA-ILD): update on prevalence, risk factors, pathogenesis, and therapy","volume":"26","author":"Sullivan","year":"2024","journal-title":"Curr Rheumatol Rep"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/art.27405","article-title":"Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study","volume":"62","author":"Bongartz","year":"2010","journal-title":"Arthritis Rheum"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s00393-023-01464-w","article-title":"Screening for rheumatoid arthritis-associated interstitial lung disease-a Delphi-based consensus statement","volume":"83","author":"Hackner","year":"2024","journal-title":"Z Rheumatol"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"4915","DOI":"10.1093\/rheumatology\/keac152","article-title":"Associations of the MUC5B promoter variant with timing of interstitial lung disease and rheumatoid arthritis onset","volume":"61","author":"McDermott","year":"2022","journal-title":"Rheumatology (Oxford)"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1542400\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T05:11:29Z","timestamp":1740373889000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1542400\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,24]]},"references-count":86,"alternative-id":["10.3389\/fmed.2025.1542400"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1542400","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,24]]},"article-number":"1542400"}}